Abiraterone is an inhibitor of CYP17A1 which is used for the treatment of castration resistant prostate cancer. Abiraterone is known to inhibit several drug metabolizing cytochrome P450 enzymes including CYP1A2, CYP2D6, CYP2C8, CYP2C9, CYP2C19, CYP3A4 and CYP3A5, but its effects on steroid metabolizing P450 enzymes are not clear. In preliminary results, we had observed inhibition of CYP21A2 by 1μM abiraterone. Here we are reporting the effect of abiraterone on activities of CYP21A2 in human adrenal cells as well as with purified recombinant CYP21A2. Cells were treated with varying concentrations of abiraterone for 24h and CYP21A2 activity was measured using [H] 17-hydroxyprogesterone as substrate. Whole steroid profile changes were determined by gas chromatography-mass spectrometry. Binding of abiraterone to purified CYP21A2 protein was measured spectroscopically. Computational docking was used to study the binding and interaction of abiraterone with CYP21A2. Abiraterone caused significant reduction in CYP21A2 activity in assays with cells and an inhibition of CYP21A2 activity was also observed in experiments using recombinant purified proteins. Abiraterone binds to CYP21A2 with an estimated Kd of 6.3μM. These inhibitory effects of abiraterone are at clinically used concentrations. A loss of CYP21A2 activity in combination with reduction of CYP17A1 activities by abiraterone could result in lower cortisol levels and may require monitoring for any potential adverse effects.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jsbmb.2017.09.007 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Detection and characterization of the types of CYP21A1P/CYP21A2 and TNXA/TNXB fused genes by long-read sequencing among children with Steroid 21-hydroxylase deficiency].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
December 2024
Department of Endocrinology and Inborn Metabolic Diseases, Fujian Children's Hospital (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian 350000, China.
Objective: To assess the diagnostic efficiency of long-read sequencing (LRS) for the determination of CYP21A1P/CYP21A2 and TNXA/TNXB fusion genotypes among children with 21-hydroxylase deficiency (21-OHD) and explore their clinical characteristics.
Methods: LRS sequencing was carried out on 30 children diagnosed with 21-OHD at the Department of Endocrinology, Fujian Children's Hospital between November 2022 and September 2023 by clinical symptoms or conventional Sanger sequencing combined with multiple ligation-dependent probe amplification (MLPA). The results of the two methods were compared.
Disordered electron transfer: New forms of defective steroidogenesis and mitochondriopathy.
J Clin Endocrinol Metab
November 2024
Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland.
Article Synopsis
- * Most steroidogenic enzymes are cytochrome P450s, requiring electron donation from specific proteins (POR or FDXR/FDX), with deficiencies in these proteins linked to various health issues, including the rare CAH caused by POR deficiency.
- * Recent research has found mutations in FDXR linked to serious neurological symptoms and adrenal insufficiency, indicating the need for interdisciplinary collaboration among specialists when evaluating these patients.
Comparison of long-read sequencing and MLPA combined with long-PCR sequencing of mutations in patients with 21-OHD.
Front Genet
November 2024
Department of Genetics, Metabolism and Endocrinology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Article Synopsis
- 21-Hydroxylase deficiency (21-OHD) is linked to mutations in the CYP21A2 gene, making genetic testing challenging due to its complex structure and high variability among patients.
- The study aimed to employ long-read sequencing (LRS) using the PacBio Sequel II platform to identify mutations in 67 patients with 21-OHD and compare the results with traditional methods like Long-PCR and MLPA.
- The analysis identified 27 pathogenic variants, with significant findings on the genotype-phenotype correlation, showing that the detection methods yielded differing results, but overall, the genotype correlated with clinical outcomes at a rate of 82.1%.
Severe Hyperandrogenism in 46,XX Congenital Adrenal Hyperplasia: Molecular Physiopathology, Late Diagnoses, and Personalized Management.
Int J Mol Sci
November 2024
Departmental Faculty of Medicine, Unicamillus-Saint Camillus International University of Health Sciences, I-00131 Rome, Italy.
Article Synopsis
- * Clinical manifestations of CAH vary widely, from severe salt-wasting forms risking adrenal crisis to milder forms that show hyperandrogenism without major hormonal deficiencies.
- * CAH in 46,XX fetuses can cause excessive androgen exposure, resulting in virilization and potential complications with gender identity and fertility later in life, raising considerations for gender transition decisions.
Late diagnosis of partial 3β-hydroxysteroid dehydrogenase type 2 deficiency - characterization of a new genetic variant.
Endocrinol Diabetes Metab Case Rep
July 2024
Department of Endocrinology, Aarhus University Hospital, Aarhus N, Denmark.
Summary: Congenital adrenal hyperplasia (CAH) is one of the most common inherited rare endocrine disorders. This case report presents two female siblings with delayed diagnosis of non-classical CAH 3β-hydroxysteroid dehydrogenase type 2 (3βHSD2D/HSD3B2) despite early hospital admission and apparent CAH manifestations such as infections, hirsutism, menstrual disturbances, and PCOS phenotype. Initially, sister 1 was misdiagnosed with PCOS and then 11-hydroxylase deficiency (CYP11B1), based on ultrasound, biochemical findings, and negative genetic testing for 21-hydroxylase deficiency (CYP21A2).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!